Medical City Invest in medical technology The virtual conference, scheduled for Tuesday, July 26, will focus on the many ways pharma companies are using digital health technology to support many aspects of their work. These applications include artificial intelligence to identify targets for drug development, the future of digital medicine, the impact of Covid-19 on clinical trials, and more.
Here’s a preview of what virtual meetings have to offer.you can Access the full agenda here.
The future of digital medicine (Sponsored by Emergn)
Digital medicine holds great promise, though so far it has been a failure story. Still, a new generation of companies is committed to transforming the digital therapeutics market. Learn from experts in pharma, digital health and commercialization.
host: Carrie Northcott, Senior Director, Digital Medicine and Translational Imaging Program Lead, Pfizer
The speaker:
- Lana Ghanem, Managing Director, Hikma Ventures
- Pierre Leurent, President, Digital Health, Aptar Pharma
- Mario Moreira, Principal Consultant, Emergn
- Abhishek Shah, Co-founder and CEO, Wellthy Therapeutics
Pharma + Digital: Here’s how to make it a match made in heaven
To say the pharma and healthtech worlds are culturally different is an understatement. But each of them has the elements the other needs. What is a strategy for better coordination and partnership.
host: Naomi Fried, CEO and Founder of Pharmstars
The speaker:
- Jessica Federer, Partner, Boston Millennium Partners
- Charles Fisher, Founder and CEO of Unlearn.AI
- Joel Krikston, Managing Director of Venture Capital and Head of Strategic Innovation Alliances, Merck Global Health Innovation Fund
- Jim Parshall, Senior Director, External Innovation, Connected Health and Devices, Eli Lilly and Company
The state of artificial intelligence in drug discovery
AI in healthcare has finally gone from being over-hyped to showing some practical applications. If it succeeds in drug discovery, it would be a huge achievement that could help speed up and reduce the cost of drug development. Learn from an expert about how we are effectively leveraging AI for drug discovery.
host: Frank Vinluan, Senior Biopharmaceutical Reporter, MedCity News
The speaker:
- Nathan Benaich, Founder and General Partner, Air Street Capital
- Chris Gibson, Co-founder and CEO, Recursion
- Najat Khan, Chief Data Science Officer, Global Head, Strategy and Operations, Janssen Pharmaceuticals
- Richard Law, Chief Commercial Officer, Exscientia
The day’s panel discussion will culminate in the Pitch Perfect competition, in which five companies seek to reinvent clinical trials with different approaches. Competition judges include:
- Cris De Luca, Digital Partner, Sanofi Ventures
- Jessica Federer, Partner, Boston Millennium Partners
- Joel Krikston, Managing Director of Venture Capital and Head of Strategic Innovation Alliances, Merck Global Health Innovation Fund
- Maxim Owen, Venture Partner, Wavemaker Three-Six0 Health
To see competing startups, Click here.
photo: Who_I_am, Getty Images
